Gilead Keeps Focus On HIV, Long-Acting Drugs And Growth Through Oncology

Three Years On, Strategy Under CEO O’Day Is Unchanged

Gilead headquarters in Foster City, CA
Gilead reports Q4 2022 earnings on 2 February • Source: Shutterstock

More from Anticancer

More from Therapeutic Category